Company News
Genpharmasec Reports No Rights Issue Proceeds Deviation
Genpharmasec Ltd filed a regulatory statement confirming no deviation in use of Rs 48.45 crore Rights Issue proceeds for Q4 FY26.
The company raised funds on 21 February 2024 for acquisition, debt rep
